Overview

Mucinex® ER 600 mg Bi-Layer Tablet Fed and Fasted

Status:
Completed
Trial end date:
2013-08-07
Target enrollment:
Participant gender:
Summary
Determine and compare the plasma concentrations of Mucinex® Extended Release (ER) 600 mg bi-layer tablet in normal healthy volunteers in fed and fasting conditions
Phase:
Phase 1
Details
Lead Sponsor:
Reckitt Benckiser LLC
Treatments:
Chlorpheniramine, phenylpropanolamine drug combination
Guaifenesin
Phenylpropanolamine